Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Prev Med. 2021 Dec 1;154:106903. doi: 10.1016/j.ypmed.2021.106903

Table 2.

Multivariate Analyses for non-alcoholic fatty liver disease (NAFLD) and subset with advanced fibrosis

Adjusted OR (95% CI) NAFLD (CAP score ≥285 dB/m) Advanced fibrosis (LSM≥ 8.6 kPa)
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
Physical activity
T1 (Reference)
T2 0.67 (0.46, 0.98) 0.65 (0.42, 0.99) 0.65 (0.42, 0.99) 0.83 (0.35, 1.96) 1.08 (0.39, 3.02) 1.11 (0.41, 2.98)
T3 0.87 (0.60, 1.26) 0.98 (0.56, 1.47) 0.98 (0.66, 1.47) 0.54 (0.31, 0.95) 0.36 (0.18, 0.72) 0.35 (0.16, 0.75)
Sedentary behavior
T1 (Reference)
T2 0.95 (0.65, 1.39) 0.98 (0.65, 1.49) 0.99 (0.65, 1.50) 0.72 (0.29, 1.79) 0.68 (0.26, 1.82) 0.57 (0.24, 1.39)
T3 1.19 (0.87, 1.63) 1.15 (0.81, 1.64) 1.16 (0.82, 1.64) 1.38 (0.57, 3.36) 1.23 (0.53, 2.84) 1.03 (0.47, 2.21)
Health Eating Index (HEI)
T1 (Reference)
T2 0.80 (0.49, 1.30) 0.75 (0.50, 1.15) 0.75 (0.50, 1.13) 0.81 (0.29, 2.28) 0.62 (0.20, 1.91) 0.69 (0.20, 2.34)
T3 0.57 (0.40, 0.82) 0.61 (0.43, 0.85) 0.60 (0.44, 0.84) 0.96 (0.37, 2.47) 0.84 (0.28, 2.49) 0.91 (0.29, 2.82)

Notes:

Abbreviations: NAFLD: non-alcoholic fatty liver disease, CAP: controlled attenuation parameter, LSM: liver stiffness measurements, CI: confidence interval, T: tertile

Models: Multivariable-adjusted logistic regression

Model 1: Adjusted for age, sex, race/ethnicity

Model 2 for NAFLD: Model 1 + Metabolic Syndrome

Model 2 for advanced fibrosis: Model 1 + Metabolic Syndrome + smoking

Model 3 for Physical Activity and Sedentary Behavior: Model 2 + total energy

Model 3 for HEI: Model 2 + total energy, physical activity, alcohol use